User profiles for Jinal N. Bhiman

Jinal Bhiman

National Institute for Communicable Diseases
Verified email at nicd.ac.za
Cited by 16285

[HTML][HTML] Detection of a SARS-CoV-2 variant of concern in South Africa

…, S Weaver, D Martin, RJ Lessells, JN Bhiman… - Nature, 2021 - nature.com
Continued uncontrolled transmission of SARS-CoV-2 in many parts of the world is creating
conditions for substantial evolutionary changes to the virus 1 , 2 . Here we describe a newly …

[HTML][HTML] Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

…, A von Gottberg, JN Bhiman… - Nature, 2022 - nature.com
The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B.1.1.529),
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …

[HTML][HTML] Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa

…, C Williamson, OG Pybus, JN Bhiman… - Nature medicine, 2022 - nature.com
Three lineages (BA.1, BA.2 and BA.3) of the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) Omicron variant of concern predominantly drove South Africa’s fourth …

[HTML][HTML] Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant

…, K Ahmed, P Aley, S Bhikha, JN Bhiman… - … England Journal of …, 2021 - Mass Medical Soc
Background Assessment of the safety and efficacy of vaccines against the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …

[HTML][HTML] SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma

…, A Von Gottberg, C Cohen, L Morris, JN Bhiman… - Nature medicine, 2021 - nature.com
SARS-CoV-2 501Y.V2 (B.1.351), a novel lineage of coronavirus causing COVID-19, contains
substitutions in two immunodominant domains of the spike protein. Here, we show that …

[HTML][HTML] Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

…, JN Bhiman, C Scheepers, N Tebeila, N Chiwandire… - The Lancet, 2022 - thelancet.com
Background The SARS-CoV-2 omicron variant of concern was identified in South Africa in
November, 2021, and was associated with an increase in COVID-19 cases. We aimed to …

[HTML][HTML] T cell responses to SARS-CoV-2 spike cross-recognize Omicron

…, V Ueckermann, T Rossouw, MT Boswell, JN Bhiman… - Nature, 2022 - nature.com
The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations 1 , 2 that
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa

…, S Weaver, D Martin, RJ Lessells, JN Bhiman… - medrxiv, 2020 - medrxiv.org
Continued uncontrolled transmission of the severe acute respiratory syndrome-related
coronavirus 2 (SARS-CoV-2) in many parts of the world is creating the conditions for significant …

[HTML][HTML] Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

…, CA Schramm, J Gorman, PL Moore, JN Bhiman… - Nature, 2014 - nature.com
Antibodies capable of neutralizing HIV-1 often target variable regions 1 and 2 (V1V2) of the
HIV-1 envelope, but the mechanism of their elicitation has been unclear. Here we define the …

[HTML][HTML] Sixteen novel lineages of SARS-CoV-2 in South Africa

…, S Pillay, N Msomi, K Mlisana, JN Bhiman… - Nature medicine, 2021 - nature.com
The first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in South
Africa was identified on 5 March 2020, and by 26 March the country was in full lockdown (…